Rudy Li's Stock Ratings

Chardan Capital Analyst

Rudy Li is an analyst at Chardan Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/13/2025

Overall Average Return

-17.3%

Smart Score

34%

Overall Average Return Percentile

14th

Number of Ratings

14
Buy NowGet Alert
05/09/2025MNMDBuy Now
Mind Medicine
$6.49208.17%
Rudy Li33%
$20 → $20MaintainsBuyGet Alert
05/09/2025PRTABuy Now
Prothena Corp
$7.98401.26%
Rudy Li33%
$40 → $40MaintainsBuyGet Alert
05/08/2025CNTABuy Now
Centessa Pharmaceuticals
$13.15128.14%
Rudy Li33%
→ $30Initiates → BuyGet Alert
05/07/2025XENEBuy Now
Xenon Pharmaceuticals
$32.1571.07%
Rudy Li33%
→ $55Initiates → BuyGet Alert
05/07/2025PRAXBuy Now
Praxis Precision Medicine
$38.40108.33%
Rudy Li33%
→ $80Initiates → BuyGet Alert
05/07/2025DRUGBuy Now
Bright Minds Biosciences
$33.20140.96%
Rudy Li33%
→ $80Initiates → BuyGet Alert
03/19/2025STOKBuy Now
Stoke Therapeutics
$9.62149.48%
Rudy Li33%
$24 → $24MaintainsBuyGet Alert
02/21/2025PRTABuy Now
Prothena Corp
$7.98401.26%
Rudy Li33%
$40 → $40MaintainsBuyGet Alert
02/19/2025STOKBuy Now
Stoke Therapeutics
$9.62149.48%
Rudy Li33%
$24 → $24MaintainsBuyGet Alert
12/20/2024PRTABuy Now
Prothena Corp
$7.98401.26%
Rudy Li33%
→ $40Initiates → BuyGet Alert
12/20/2024STOKBuy Now
Stoke Therapeutics
$9.62149.48%
Rudy Li33%
→ $24Initiates → BuyGet Alert
12/20/2024MNMDBuy Now
Mind Medicine
$6.49208.17%
Rudy Li33%
→ $20Initiates → BuyGet Alert
04/15/2024MNMDBuy Now
Mind Medicine
$6.49208.17%
Rudy Li33%
→ $20Initiates → OutperformGet Alert
04/24/2023PRTABuy Now
Prothena Corp
$7.98902.52%
Rudy Li33%
→ $80Initiates → OutperformGet Alert